-
3281
Development of Radiolabeled Compounds for Molecular Imaging and Imaging-Based Therapy
Published 2015-01-01Get full text
Article -
3282
Corrigendum to “NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation”
Published 2018-01-01Get full text
Article -
3283
-
3284
Primary Retroperitoneal Malignant Melanoma with Involvement of Iliac Artery and Vein
Published 2021-01-01Get full text
Article -
3285
-
3286
Renal Stem Cells, Tissue Regeneration, and Stem Cell Therapies for Renal Diseases
Published 2015-01-01Get full text
Article -
3287
I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations
Published 2022-06-01“…Enrolment and adaptation of the trial design are ongoing.Ethics and dissemination ISPY COVID-19 operates under a central institutional review board via Wake Forest School of Medicine IRB00066805. Data generated from this trial will be reported in peer-reviewed medical journals.Trial registration number NCT04488081.…”
Get full text
Article -
3288
-
3289
-
3290
-
3291
-
3292
-
3293
-
3294
-
3295
Pretreatment with G-CSF Could Enhance the Antifibrotic Effect of BM-MSCs on Pulmonary Fibrosis
Published 2019-01-01Get full text
Article -
3296
-
3297
Digital health for early psychosis in Ghana: patient and caregiver needs and preferences
Published 2025-01-01Get full text
Article -
3298
-
3299
-
3300